Kelsey Mariner Selected Research

Neoplasms (Cancer)

1/2022	Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells.
1/2021	Harnessing the polyamine transport system to treat BRAF inhibitor-resistant melanoma.
10/2020	Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.
1/2019	Polyamine-stimulation of arsenic-transformed keratinocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kelsey Mariner Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

4	PolyaminesIBA 01/2022 - 01/2019
1	Eflornithine (Ornidyl)FDA Link 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	rucaparibIBA 01/2022
1	matrigelIBA 01/2021
1	PLX 4720IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	LigandsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 10/2020
1	ArsenicIBA 01/2019
1	Toll-Like Receptor 4IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2020
1	Immunotherapy 10/2020